Intranasal Bevacizumab for HHT-Related Epistaxis

Clinical trial NCT02389959 · COMPLETED

Trial details

NCT number: NCT02389959
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

HHT Hereditary Hemorrhagic Telangiectasia Epistaxis Nose Bleeds Nasal Bleeding

Start date: 2014-08-04
Primary completion: 2020-01-23
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.